Demoxytocin: Difference between revisions
No edit summary |
No edit summary |
||
Line 36: | Line 36: | ||
}} | }} | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Demoxytocin''' ([[International Nonproprietary Name|INN]], trade name '''Sandopart''') or '''deaminooxytocin''', is an [[obstetric]] [[pharmaceutical drug|drug]] often{{fact|date=March 2012}} used in the prevention of [[puerperal]] [[mastitis]].<ref>{{cite pmid|468056}}</ref> It is an [[analog (chemistry)|analogue]] of [[oxytocin]]. | '''Demoxytocin''' ([[International Nonproprietary Name|INN]], trade name '''Sandopart''') or '''deaminooxytocin''', is an [[obstetric]] [[pharmaceutical drug|drug]] often{{fact|date=March 2012}} used in the prevention of [[puerperal]] [[mastitis]].<ref>{{cite pmid|468056}}</ref> It is an [[analog (chemistry)|analogue]] of [[oxytocin]]. | ||
Line 43: | Line 46: | ||
{{Pituitary and hypothalamic hormones and analogues}} | {{Pituitary and hypothalamic hormones and analogues}} | ||
[[Category:Neuropeptides]] | [[Category:Neuropeptides]] | ||
[[Category: | [[Category:Drug]] | ||
Revision as of 18:22, 8 April 2015
{{chembox | Verifiedfields = changed | UNII_Ref = | UNII = 2N9HM3X95F | verifiedrevid = 444602345 |ImageFile=Demoxytocin.svg.png |ImageSize= |IUPACName= 2-[(1-{[13-(butan-2-yl)-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl)formamido]-N-(carbamoylmethyl)-4-methylpentanamide |OtherNames= |Section1=! colspan=2 style="background: #f8eaba; text-align: center;" |Identifiers
|-
|
|
|-
|
|
|-
| ChEMBL
|
|-
| ECHA InfoCard
| Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
|-
| KEGG
|
|- | MeSH | deaminooxytocin |-
|
|
|-
| colspan="2" |
- CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
|- |Section2=! colspan=2 style="background: #f8eaba; text-align: center;" |Properties
|-
|
| C43H65N11O12S2
|- | Molar mass
| 992.1727
|- |Section3= }}
WikiDoc Resources for Demoxytocin |
Articles |
---|
Most recent articles on Demoxytocin Most cited articles on Demoxytocin |
Media |
Powerpoint slides on Demoxytocin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Demoxytocin at Clinical Trials.gov Clinical Trials on Demoxytocin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Demoxytocin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Demoxytocin Discussion groups on Demoxytocin Patient Handouts on Demoxytocin Directions to Hospitals Treating Demoxytocin Risk calculators and risk factors for Demoxytocin
|
Healthcare Provider Resources |
Causes & Risk Factors for Demoxytocin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Demoxytocin (INN, trade name Sandopart) or deaminooxytocin, is an obstetric drug often[citation needed] used in the prevention of puerperal mastitis.[1] It is an analogue of oxytocin.
References
- ↑ PMID 468056 (PMID 468056)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
- Pages with script errors
- Pages with incomplete PMID references
- Articles without InChI source
- Chemical pages without ChemSpiderID
- Articles without UNII source
- Chemical articles with unknown parameter in Chembox
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- All articles with unsourced statements
- Articles with unsourced statements from March 2012
- Articles with invalid date parameter in template
- Neuropeptides
- Drug